| Name | Title | Contact Details |
|---|---|---|
Mark Finkle |
VP of Engineering (Productivity & Developer Program) | Profile |
Kaiser Permanente is a physician-led medical group in Northern and Central California that provides quality medical care to over 3.8 million members. They practice a multi-lingual, culturally inclusive approach to care that celebrates the diversity of ...
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.
Integris Southwest Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Integris Southwest Medical Center is based in Oklahoma City, OK. You can find more information on Integris Southwest Medical Center at www.integrishealth.com
BeneFit Cosmetics LLC is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. BeneFit Cosmetics LLC is based in San Francisco, CA. You can find more information on BeneFit Cosmetics LLC at www.benefitcosmetics.com
ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex`s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product, Tru Niagen® — available at www.truniagen.com and through partnerships with global retailers and distributors.